Distribution date: 08 December 2022 | Final date for Comment: 05 May 2025

https://www.in.gov.br/web/dou/-/retificacao-447330077

Products Covered: HS (3003-3004) - Herbal medicinal products

Regulation Type: Corrigendum to Regular Notification

Distribution date: 12 December 2022 | Final date for Comment: 05 May 2025

The Committee for Veterinary Control and Surveillance of the Ministry of Agriculture of Kazakhstan reports that on the basis of the official notification of the World Organisation for Animal Health (WAHIS), outbreaks of avian influenza were registered in the states of Utah, Oregon and Washington, United States of America. In this regard, since 11 August 2022, temporary restrictions have been introduced on the importation to the territory of Kazakhstan from the states of Utah, Oregon and Washington, United States of America of live poultry and hatching eggs, down and feathers, poultry meat and all types of poultry products that have not undergone heat treatment (at least 70 °C), feed and feed additives for birds (excluding feed additives of plant origin, chemical and microbiological synthesis), trophies of the chase that have not undergone taxidermy treatment (feather game), used equipment for keeping, slaughtering and cutting birds, as well as transit through the territory of Kazakhstan of live poultry from the above territories. 

Products Covered: Live poultry, hatching eggs, down and feathers, poultry meat, all poultry products, feed and feed additives for birds, trophies of the chase, used equipment for the maintenance, slaughter and cutting of birds

Regulation Type: Emergency notifications (SPS)

Distribution date: 12 December 2022 | Final date for Comment: 10 February 2023

This Draft Uganda standard specifies the requirements, test methods and sampling of limestone for industrial use. This Draft Uganda Standard does not cover limestone for building, agricultural, metallurgical, glass and ceramic industries. Physical requirements, such as specific gravity, porosity, compressive strength and size of stone are not included in this Draft Uganda Standard, as these requirements will depend on, amongst others, the types of kilns used for burning limestone.

Products Covered: Limestone flux; limestone and other calcareous stone, of a kind used for the manufacture of lime or cement (HS code(s): 2521); Cement. Gypsum. Lime. Mortar (ICS code(s): 91.100.10)

Regulation Type: Regular notification

Distribution date: 12 December 2022 | Final date for Comment: 10 February 2023

This Draft East African standard provides guidelines for the design and execution of studies to evaluate the performance of mosquito repellents formulated and prepared for application directly to human skin. These guidelines apply to products in any formulation intended to be applied directly to human skin. The purpose of these guidelines is to provide specific and standardized procedures and criteria for efficacy testing and evaluation of mosquito repellents for human skin. Their aim is to harmonize the testing procedures carried out in different laboratories and institutions in order to generate comparable data for registering and labelling such products by the national regulatory authorities. However, the requirements for registration of pesticides, including repellents, are determined by the national regulatory authorities. The guidelines provide guidance and procedures on laboratory studies, field trials and evaluation of technical material used in mosquito repellent products and on the methods used to determine their application rate(s) and effectiveness. Guidance is also provided on the single-dose evaluation of formulated repellent products. With some modification, the guidelines can be used to determine the repellency of candidate compounds for other flying insects that blood-feed on humans. Detailed treatment and analysis of repellent safety and toxicity data are beyond the scope of these guidelines, and it is assumed that preliminary human safety assessments have been undertaken before the material(s) are applied to human skin. Any side-effects and/or undesirable characteristics experienced in association with the application and use of repellents in laboratory studies and field trials should be recorded and reported. The protocol must include provision for medical care and the reporting of adverse events. Products submitted for laboratory studies and/or field trials should be accompanied by the Material Safety Data Sheet, the labelling recommendation and the manufacturer’s certification that the product is within the company's manufacturing specifications for that product. Independent physical and chemical assessment may be required before initiating the efficacy studies. Biological tests are subject to the variation that accompanies living organisms. Studies should therefore be conducted under the close supervision of personnel familiar with biological testing of repellents and with sound scientific and experimental procedures; the principles of good laboratory practice or other suitable quality schemes such as the International Organization for Standardization should be applied.

Products Covered: Insecticides, put up in forms or packings for retail sale or as preparations or articles (excl. goods of subheadings 3808.52 to 3808.69) (HS code(s): 380891); Insecticides (ICS code(s): 65.100.10)

Regulation Type: Regular notification

Distribution date: 12 December 2022 | Final date for Comment: 10 February 2023

This Draft East African standard provides guidelines for the design and execution of studies to evaluate the performance of mosquito repellents formulated and prepared for application directly to human skin. These guidelines apply to products in any formulation intended to be applied directly to human skin. The purpose of these guidelines is to provide specific and standardized procedures and criteria for efficacy testing and evaluation of mosquito repellents for human skin. Their aim is to harmonize the testing procedures carried out in different laboratories and institutions in order to generate comparable data for registering and labelling such products by the national regulatory authorities. However, the requirements for registration of pesticides, including repellents, are determined by the national regulatory authorities. The guidelines provide guidance and procedures on laboratory studies, field trials and evaluation of technical material used in mosquito repellent products and on the methods used to determine their application rate(s) and effectiveness. Guidance is also provided on the single-dose evaluation of formulated repellent products. With some modification, the guidelines can be used to determine the repellency of candidate compounds for other flying insects that blood-feed on humans. Detailed treatment and analysis of repellent safety and toxicity data are beyond the scope of these guidelines, and it is assumed that preliminary human safety assessments have been undertaken before the material(s) are applied to human skin. Any side-effects and/or undesirable characteristics experienced in association with the application and use of repellents in laboratory studies and field trials should be recorded and reported. The protocol must include provision for medical care and the reporting of adverse events. Products submitted for laboratory studies and/or field trials should be accompanied by the Material Safety Data Sheet, the labelling recommendation and the manufacturer’s certification that the product is within the company's manufacturing specifications for that product. Independent physical and chemical assessment may be required before initiating the efficacy studies. Biological tests are subject to the variation that accompanies living organisms. Studies should therefore be conducted under the close supervision of personnel familiar with biological testing of repellents and with sound scientific and experimental procedures; the principles of good laboratory practice or other suitable quality schemes such as the International Organization for Standardization should be applied.

Products Covered: Insecticides, put up in forms or packings for retail sale or as preparations or articles (excl. goods of subheadings 3808.52 to 3808.69) (HS code(s): 380891); Insecticides (ICS code(s): 65.100.10)

Regulation Type: Regular notification

Distribution date: 12 December 2022 | Final date for Comment: 10 February 2023

This Draft East African standard provides guidelines for the design and execution of studies to evaluate the performance of mosquito repellents formulated and prepared for application directly to human skin. These guidelines apply to products in any formulation intended to be applied directly to human skin. The purpose of these guidelines is to provide specific and standardized procedures and criteria for efficacy testing and evaluation of mosquito repellents for human skin. Their aim is to harmonize the testing procedures carried out in different laboratories and institutions in order to generate comparable data for registering and labelling such products by the national regulatory authorities. However, the requirements for registration of pesticides, including repellents, are determined by the national regulatory authorities. The guidelines provide guidance and procedures on laboratory studies, field trials and evaluation of technical material used in mosquito repellent products and on the methods used to determine their application rate(s) and effectiveness. Guidance is also provided on the single-dose evaluation of formulated repellent products. With some modification, the guidelines can be used to determine the repellency of candidate compounds for other flying insects that blood-feed on humans. Detailed treatment and analysis of repellent safety and toxicity data are beyond the scope of these guidelines, and it is assumed that preliminary human safety assessments have been undertaken before the material(s) are applied to human skin. Any side-effects and/or undesirable characteristics experienced in association with the application and use of repellents in laboratory studies and field trials should be recorded and reported. The protocol must include provision for medical care and the reporting of adverse events. Products submitted for laboratory studies and/or field trials should be accompanied by the Material Safety Data Sheet, the labelling recommendation and the manufacturer’s certification that the product is within the company's manufacturing specifications for that product. Independent physical and chemical assessment may be required before initiating the efficacy studies. Biological tests are subject to the variation that accompanies living organisms. Studies should therefore be conducted under the close supervision of personnel familiar with biological testing of repellents and with sound scientific and experimental procedures; the principles of good laboratory practice or other suitable quality schemes such as the International Organization for Standardization should be applied.

Products Covered: Insecticides, put up in forms or packings for retail sale or as preparations or articles (excl. goods of subheadings 3808.52 to 3808.69) (HS code(s): 380891); Insecticides (ICS code(s): 65.100.10)

Regulation Type: Regular notification

Distribution date: 12 December 2022 | Final date for Comment: 10 February 2023

This Draft East African standard provides guidelines for the design and execution of studies to evaluate the performance of mosquito repellents formulated and prepared for application directly to human skin. These guidelines apply to products in any formulation intended to be applied directly to human skin. The purpose of these guidelines is to provide specific and standardized procedures and criteria for efficacy testing and evaluation of mosquito repellents for human skin. Their aim is to harmonize the testing procedures carried out in different laboratories and institutions in order to generate comparable data for registering and labelling such products by the national regulatory authorities. However, the requirements for registration of pesticides, including repellents, are determined by the national regulatory authorities. The guidelines provide guidance and procedures on laboratory studies, field trials and evaluation of technical material used in mosquito repellent products and on the methods used to determine their application rate(s) and effectiveness. Guidance is also provided on the single-dose evaluation of formulated repellent products. With some modification, the guidelines can be used to determine the repellency of candidate compounds for other flying insects that blood-feed on humans. Detailed treatment and analysis of repellent safety and toxicity data are beyond the scope of these guidelines, and it is assumed that preliminary human safety assessments have been undertaken before the material(s) are applied to human skin. Any side-effects and/or undesirable characteristics experienced in association with the application and use of repellents in laboratory studies and field trials should be recorded and reported. The protocol must include provision for medical care and the reporting of adverse events. Products submitted for laboratory studies and/or field trials should be accompanied by the Material Safety Data Sheet, the labelling recommendation and the manufacturer’s certification that the product is within the company's manufacturing specifications for that product. Independent physical and chemical assessment may be required before initiating the efficacy studies. Biological tests are subject to the variation that accompanies living organisms. Studies should therefore be conducted under the close supervision of personnel familiar with biological testing of repellents and with sound scientific and experimental procedures; the principles of good laboratory practice or other suitable quality schemes such as the International Organization for Standardization should be applied.

Products Covered: Insecticides, put up in forms or packings for retail sale or as preparations or articles (excl. goods of subheadings 3808.52 to 3808.69) (HS code(s): 380891); Insecticides (ICS code(s): 65.100.10)

Regulation Type: Regular notification

Distribution date: 12 December 2022 | Final date for Comment: 10 February 2023

This Draft East African standard provides guidelines for the design and execution of studies to evaluate the performance of mosquito repellents formulated and prepared for application directly to human skin. These guidelines apply to products in any formulation intended to be applied directly to human skin. The purpose of these guidelines is to provide specific and standardized procedures and criteria for efficacy testing and evaluation of mosquito repellents for human skin. Their aim is to harmonize the testing procedures carried out in different laboratories and institutions in order to generate comparable data for registering and labelling such products by the national regulatory authorities. However, the requirements for registration of pesticides, including repellents, are determined by the national regulatory authorities. The guidelines provide guidance and procedures on laboratory studies, field trials and evaluation of technical material used in mosquito repellent products and on the methods used to determine their application rate(s) and effectiveness. Guidance is also provided on the single-dose evaluation of formulated repellent products. With some modification, the guidelines can be used to determine the repellency of candidate compounds for other flying insects that blood-feed on humans. Detailed treatment and analysis of repellent safety and toxicity data are beyond the scope of these guidelines, and it is assumed that preliminary human safety assessments have been undertaken before the material(s) are applied to human skin. Any side-effects and/or undesirable characteristics experienced in association with the application and use of repellents in laboratory studies and field trials should be recorded and reported. The protocol must include provision for medical care and the reporting of adverse events. Products submitted for laboratory studies and/or field trials should be accompanied by the Material Safety Data Sheet, the labelling recommendation and the manufacturer’s certification that the product is within the company's manufacturing specifications for that product. Independent physical and chemical assessment may be required before initiating the efficacy studies. Biological tests are subject to the variation that accompanies living organisms. Studies should therefore be conducted under the close supervision of personnel familiar with biological testing of repellents and with sound scientific and experimental procedures; the principles of good laboratory practice or other suitable quality schemes such as the International Organization for Standardization should be applied.

Products Covered: Insecticides, put up in forms or packings for retail sale or as preparations or articles (excl. goods of subheadings 3808.52 to 3808.69) (HS code(s): 380891); Insecticides (ICS code(s): 65.100.10)

Regulation Type: Regular notification

Distribution date: 12 December 2022 | Final date for Comment: 10 February 2023

This Draft East African Standard specifies the requirements, sampling and test methods for skin applied mosquito repellents in form of sprays and roll-ons.

Products Covered: Insecticides, put up in forms or packings for retail sale or as preparations or articles (excl. goods of subheadings 3808.52 to 3808.69) (HS code(s): 380891); Insecticides (ICS code(s): 65.100.10)

Regulation Type: Regular notification

Distribution date: 12 December 2022 | Final date for Comment: 10 February 2023

This Draft East African Standard specifies the requirements, sampling and test methods for skin applied mosquito repellents in form of lotions, creams, gels and ointments.

Products Covered: Insecticides, put up in forms or packings for retail sale or as preparations or articles (excl. goods of subheadings 3808.52 to 3808.69) (HS code(s): 380891); Insecticides (ICS code(s): 65.100.10)

Regulation Type: Regular notification